Pharmacy News

Subscribe to Pharmacy News feed
PharmaTimes - The latest news in healthcare and life sciences - News RSS
Updated: 1 hour 8 min ago

Finalists give their thoughts on the Medical & Scientific Excellence Awards

The PharmaTimes Medical & Scientific Excellence Awards have been praised by last year’s finalists on it’s great learning and development process.

Mallinckrodt, Silence Theraputics to commercialise RNAi therapeutics

The agreement provides Mallinckrodt with an exclusive worldwide license for C3 (SLN500) - a preclinical asset that targets a specific protein in the complement pathway.

MHRA gives Bavencio, Inlyta combo Early Access to Medicines status

The opinion is for the indication of RCC, the most common kind of kidney cancer found in adults.

AMR Centre, Shionogi team up for superbug therapy

The therapy has already produced encouraging results in pre-clinical studies and regulatory toxicology tests in preparation for first-in-human clinical trials.

Government to invest £16m in 'life-saving' medical advances

The funding is available are part of the Government’s modern Industrial Strategy.

UK prescribed ‘unnecessarily long courses’ of antibiotics

NICE reviewed a BMJ study and determined that the findings suggest that guidance on antibiotic use is not being implemented as well as it could be in all areas which may lead to antibiotic overuse.

Animal experiment stats show reluctance to embrace modern tools

A shockingly high number of dogs, mice, cats, rabbits and other animals are still suffering in invasive, painful and sometimes lethal experiments in British laboratories.

Bayer, BMS, Ono team up to investigate Stivarga, Opdivo combo

Encouraging early data have been seen with the studied combination, as in a Phase Ib investigator sponsored trial from Japan called REGONIVO

Robots to help produce new class of antibiotics

The antibiotics, known as class II polyketides, are also naturally produced by soil bacteria and have antimicrobial properties.

Boehringer expands IPF pipeline with addition of BBT-877

Under the terms of the deal Bridge Biotherapeutics will receive upfront and near term payments of EUR 45million and is eligible to receive up to more than EUR 1.1billion in potential payments.

Mallinckrodt halts mid-stage Acthar trial citing pneumonia risk

ALS is a progressive neurodegenerative disease that affects motor neuron cells in the brain and the spinal cord.

Novartis’ sickle cell drug wins FDA priority review

The governing body accepted the company's Biologics License Application for prevention of vaso-occlusive crises.

Gender imbalance expected in senior pharma roles until 2090

More than 85% of companies have no women executives on their main boards, only 9% of executive directors on main boards are women, and a mere 17% of FTSE350 executive committee members are women.

Boots UK to offer cystitis test

During the pilot over the last seven months over 1,000 customers accessed the service, with the majority of them completing the service in the same day.

‘World’s most accurate blood test’ launched in UK

The Mitomic Prostate Test has a 92% sensitivity, which means that men with a positive result can be referred for immediate medical intervention.

PureTech acquires LYT-100 to treat lymphedema

The candidate, LYT-100, demonstrated anti-fibrotic and anti-inflammatory mechanisms in pre-clinical studies.

Boehringer enriches cancer immunology portfolio with AMAL Therapeutics acquisition

AMAL’s lead vaccine, ATP128, is currently developed for stage IV colorectal cancer and is slated to begin first-in-human trials later this month.

Roche’s Genentech inks deal with Sosei Heptares

Under the terms of the agreement, Sosei Heptares is eligible to receive US$26 million in upfront and near-term payments.

NICE U-turn for Kisqali in breast cancer

NICE has recommended Novartis’ Kisqali just three months after its initial rejection.

Pistoia Alliance launches FAIR implementation ‘toolkit’

The ‘toolkit’, will be available to help companies implement the FAIR guiding principles for data management and stewardship.